Want to see HK:2327 full AI Analyst Report?
Meilleure Health International Industry Group Limited (2327) AI Stock Analysis
Top Page
Meilleure Health International Industry Group Limited
(HKEX:2327)
Weak financial performance from sharp revenue declines and operational challenges is the primary driver, compounded by bearish technical indicators, though supported by reasonable valuation.
Meilleure Health International Industry Group Limited (2327) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 689.41M
- Dividend Yield
- 3.24%
- Average Volume (3M)
- 200.95K
- Price to Earnings (P/E)
- 13.5
- Beta (1Y)
- 0.21
- Revenue Growth
- 382.03%
- EPS Growth
- 31.25%
- Country
- Hong Kong
- Employees
- 43
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Conglomerates
Meilleure Health International Industry Group Limited Business Overview & Revenue Model
Company Description
Meilleure Health International Industry Group Limited functions as an investment holding company, overseeing a broad spectrum of ventures in Hong Kong, the People's Republic of China, and other international markets. Its diverse operations include in...
Meilleure Health International Industry Group Limited Financial Statement Overview
Summary
Revenue declined sharply from 265M to 37M with recent negative EBIT, volatile cash flows, and rising debt, partially offset by stable assets and equity.
Income Statement
35NegativeBalance Sheet
55NeutralCash Flow
40Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 183.63M | 36.52M | 50.68M | 129.30M | 119.89M | 253.03M |
| Gross Profit | 36.93M | 22.63M | 28.91M | 78.09M | 66.76M | 100.93M |
| EBITDA | 2.10M | -8.61M | 56.52M | 71.38M | 55.46M | 108.73M |
| Net Income | 51.17M | 37.98M | 32.48M | 40.83M | 17.82M | 60.32M |
Balance Sheet | ||||||
| Total Assets | 1.79B | 1.82B | 1.67B | 1.70B | 1.71B | 1.74B |
| Cash, Cash Equivalents and Short-Term Investments | 10.86M | 20.18M | 29.94M | 106.31M | 210.99M | 380.39M |
| Total Debt | 291.39M | 380.96M | 303.06M | 297.06M | 249.13M | 170.42M |
| Total Liabilities | 483.04M | 567.34M | 467.29M | 442.89M | 384.18M | 306.35M |
| Stockholders Equity | 1.30B | 1.25B | 1.20B | 1.25B | 1.32B | 1.43B |
Cash Flow | ||||||
| Free Cash Flow | -28.34M | -50.60M | 188.62M | -137.32M | 42.10M | -89.79M |
| Operating Cash Flow | -28.34M | -50.02M | 188.75M | -136.49M | 43.15M | -83.27M |
| Investing Cash Flow | 122.64M | 14.64M | -253.98M | 53.72M | -134.76M | 161.56M |
| Financing Cash Flow | -96.84M | 18.07M | -6.39M | -18.90M | 41.93M | -38.22M |
Meilleure Health International Industry Group Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2327, the sentiment is Negative. The current price of 0.17 is below the 20-day moving average (MA) of 0.19, below the 50-day MA of 0.22, and below the 200-day MA of 0.25, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 24.58 is Positive, neither overbought nor oversold. The STOCH value of 60.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2327.
Meilleure Health International Industry Group Limited Peers Comparison
Overall Rating
HK:816276Outperform
HK:002563Neutral- HK:232747Neutral
HK:822745Neutral
HK:047443Neutral
HK:068937Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:8162 | 76Outperform | HKD 567.31M | 5.43 | 45.38% | ― | 18.31% | 37.80% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| HK:0025 | 63Neutral | HKD 1.36B | 3.24 | 4.37% | 6.67% | -11.27% | ― |
| HK:2327 | 47Neutral | HKD 690.32M | 13.49 | 4.01% | 3.24% | 382.03% | 31.25% |
| HK:8227 | 45Neutral | HKD 468.71M | -43.55 | 15.38% | ― | ― | ― |
| HK:0474 | 43Neutral | HKD 1.28B | 3.04 | 81.64% | ― | -57.48% | ― |
| HK:0689 | 37Underperform | HKD 185.77M | -13.70 | -4.03% | ― | -7.84% | -264.60% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2327 | Meilleure Health International Industry Group Limited | 0.17 | -0.11 | -38.85% | |
| HK:8227 | Xi'an Haitiantian Holdings Co Class H | 0.25 | 0.13 | 105.83% | |
| HK:0025 | Chevalier International Holdings Limited | 4.50 | 0.86 | 23.66% | |
| HK:0474 | Aceso Life Science Group Limited | 0.14 | 0.04 | 44.00% | |
| HK:0689 | EPI (Holdings) Limited | 0.10 | -0.02 | -18.70% | |
| HK:8162 | Loco Hong Kong Holdings Ltd | 0.57 | -0.01 | -1.72% |
Meilleure Health International Industry Group Limited Corporate Events
Meilleure Health to Acquire Wholly Owned Subsidiary in Connected HK$35.2 Million Deal
Meilleure Health International Industry Group Limited has agreed to acquire the entire issued share capital of a target company for HK$35.2 million, using a wholly owned subsidiary as purchaser. Following completion, the target company will become an...
Meilleure Health Declares Interim Cash Dividend for First Half of 2026
Meilleure Health International Industry Group Limited has declared an ordinary interim cash dividend of HKD 0.0015 per share for the six months ended 30 June 2026, for the financial year ending 31 December 2026. The move signals the board’s dec...
Meilleure Health Profits Surge on Revenue Jump and JV Gains
Meilleure Health International Industry Group Limited reported a sharp increase in unaudited interim revenue to HK$164.6 million for the six months ended 30 June 2026, up from HK$17.5 million a year earlier, lifting gross profit to HK$28.5 million. N...
Meilleure Health Updates Bermuda Registered Office While Keeping Hong Kong Share Registrar
Meilleure Health International Industry Group Limited has announced that, with effect from 3 August 2026, its registered office and principal share registrar and transfer office in Bermuda will relocate to Richmond House, 12 Par-la-Ville Road, Hamilt...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 17, 2026